您的位置: 专家智库 > >

国家自然科学基金(81000928)

作品数:2 被引量:11H指数:2
相关作者:邓欢涂炜周珍珍黄焕军何嘉怡更多>>
相关机构:华中科技大学更多>>
发文基金:湖北省自然科学基金国家自然科学基金更多>>
相关领域:医药卫生更多>>

文献类型

  • 2篇中文期刊文章

领域

  • 2篇医药卫生

主题

  • 1篇原发性
  • 1篇原发性肝癌
  • 1篇正相关关系
  • 1篇趋化
  • 1篇细胞
  • 1篇细胞癌
  • 1篇小干扰RNA
  • 1篇肝癌
  • 1篇肝细胞
  • 1篇肝细胞癌
  • 1篇靶向
  • 1篇MTDH
  • 1篇ADHESI...
  • 1篇AEG-1
  • 1篇CELL_L...
  • 1篇CHEMOT...
  • 1篇HEPG2
  • 1篇小干扰

机构

  • 1篇华中科技大学

作者

  • 1篇田德安
  • 1篇夏羽佳
  • 1篇何嘉怡
  • 1篇黄焕军
  • 1篇周珍珍
  • 1篇涂炜
  • 1篇邓欢

传媒

  • 1篇胃肠病学和肝...
  • 1篇Journa...

年份

  • 1篇2013
  • 1篇2012
2 条 记 录,以下是 1-2
排序方式:
靶向MTDH的小干扰RNA对人原发性肝癌细胞HepG2骨架重排的影响被引量:3
2013年
目的构建人MTDH基因的shRNA干扰载体,并观察其对原发性肝癌细胞HepG2骨架重排的影响。方法针对MTDH基因的不同部位设计3对shRNA的寡核苷酸片段,克隆到载体pGCsilencerTM H1/Neo中,RT-PCR、Western blotting及免疫荧光检测转染后MTDH mRNA和蛋白表达变化情况,并筛选最佳抑制效率的shRNA干扰载体,并将其转染人原发性肝癌细胞HepG2,用罗丹明标记的鬼笔环肽显示沉默MTDH基因后对人原发性肝癌细胞HepG2骨架蛋白F_actin的改变。结果靶向MTDH干扰质粒构建成功。与转空载体的阴性对照组及未转染组比较,转染pGCsilencerTM H1/Neo-MTDH-shRNA后,HepG2中MTDH mRNA和蛋白表达明显降低,其中以pGCsilencerTM H1/Neo-MTDH-S1最为明显,达到90%以上;细胞形态及细胞骨架显示转染pGCsilencerTMH1/Neo-MTDH-S1的细胞骨架蛋白F_actin发生重排。结论成功构建并筛选最佳抑制效率的靶向MTDH干扰pGCsilencerTM H1/Neo-MTDH-S1,该载体能有效重排肝癌细胞骨架。
周珍珍邓欢黄焕军夏羽佳涂炜何嘉怡田德安
关键词:肝细胞癌MTDH小干扰RNAHEPG2
Expression of Metadherin/AEG-1 Gene Is Positively Related to Orientation Chemotaxis and Adhesion of Human Hepatocellular Carcinoma Cell Lines of Different Metastatic Potentials被引量:9
2012年
Metastasis contributes to the poor prognosis of hepatocellular carcinoma (HCC). However, the mechanism through which a primary HCC cell develops into a metastatic phenotype is not well understood. The purpose of this study was to examine the correlation between metadherin (MTDH)/ astrocyte elevated gene-1 (AEG-1) expression in HCC cell lines of different metastatic potentials and such metastatic phenotypes as orientation chemotaxis and adhesion. MTDH/AEG-1 expression was detected by RT-PCR and western blotting in HCC cell lines (HepG2, Huh7, Sk-HEP-1, MHCC-97H). Distribution of MTDH/AEG-1 was observed by immunofluorescence staining and confocal laser scanning microscopy. The abilities of orientation chemotaxis and adhesion and the index of interaction between HCC cell lines and microvascular endothelial cell lines (MVECs, including HUVECs and HPMECs) were measured by chemotaxis assay and adhesion assay, respectively. The results showed that MTDH/AEG-1 protein expression was significantly higher in high metastatic potential cancer cell lines (Sk-HEP-1, MHCC-97H ) than in low metastatic potential cell lines (HepG2, Huh7) (P<0.05). The MTDH/AEG-1 protein was localized in the perinuclear region of HCC cells. Furthermore, the abilities of orientation chemotaxis and adhesion of HCC cells to HPMECs were increased as compared with those of HCC cells to HUVECs (P<0.05). The abilities of orientation chemotaxis and adhesion were much stronger in Sk-HEP-1 and MHCC-97H cells with MTDH/AEG-1 highly expressed than in HepG2 and Huh7 cells with MTDH/AEG-1 lowly expressed (P<0.05). These results suggested that the expression of MTDH/AEG-1 gene in HCC cell lines of different metastatic potentials was closely positively related to the abilities of orientation chemotaxis and adhesion of HCC cells. It was deduced that MTDH/AEG-1 might play a pivotal role in the lung-specific metastasis of HCC, which may be medi-ated through orientation chemotaxis and adhesion abilities of HCC cells. MTDH/AEG-1 may serve as a potential therapeutic targ
周珍珍邓欢晏维黄焕军邓玥灵黎媛田德安
关键词:正相关关系趋化
共1页<1>
聚类工具0